Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Restriction genes for retroviruses influence the risk of multiple sclerosis.
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Modeling cognition and disease using human glial chimeric mice.
Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
Evidence of aquaporin involvement in human central pontine myelinolysis.
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
In vivo imaging of human neuroinflammation.
A Two Sample Distribution-Free Test for Functional Data with Application to a Diffusion Tensor Imaging Study of Multiple Sclerosis.
Autonomic dysfunction, immune regulation, and multiple sclerosis.
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.
Volumetric Examination of MS Plaques and Correlation with EDSS Ratings.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Association of IL-23 and its receptor gene single nucleotide polymorphisms with Multiple Sclerosis in Chinese Southern Population.

Pages